Skip to content
Search

Latest Stories

Health committee’s new report calls for urgent pharmacy workforce plan

The Health Committee’s new report has reminded the government of a much-needed pharmacy workforce plan to support recruitment, training, and retention of staff.

The report makes a number of recommendations to optimise workloads across primary care, reduce pressure on general practice and hospitals, and support the integrated care systems.


It also recognises the potential of pharmacist independent prescribers to support patient care, backed by appropriate supervision, training, and opportunities for professional development.

RPS England gave evidence to MPs on the Committee at a public hearing in May, highlighting key issues to support the pharmacy workforce.

RPS director for England, Ravi Sharma, said: “Today’s report underlines the urgent need for the Government to set out a comprehensive workforce plan for health and care.

“It rightly recognises that boosting recruitment and retention, supporting staff wellbeing, fostering inclusion and diversity, and investing in education and training will be crucial to the future of the NHS.

“Pharmacy teams will play a key role in the NHS recovery, but with continued pressures on staff we need support for the workforce so they can keep looking after patients.

“The next generation of pharmacist independent prescribers will make a huge difference to patient care, but there are some key factors to make the most of their skills.

“I would urge the Government and NHS to listen to the Committee’s call for an integrated and funded workforce plan for pharmacy, which ensures that all pharmacists have adequate access to supervision, training, and protected learning time, along with clear structures for professional development.”

Responding to the report, Malcolm Harrison, CEO of the Company Chemists' Association, called it "yet another reminder that the entire healthcare system is suffering from recruitment and retention challenges - and that community pharmacy is not immune.

"We wholeheartedly support the Committee’s call for a funded and integrated workforce plan – something that the CCA has advocated for some time, and it must be published without delay.

"We also agree the plan must account for the onset of all newly qualified pharmacists eventually becoming independent prescribers. Greater opportunities must also be granted for independent prescribers in community settings, to utilise their newly acquired skills. As the report highlights, pharmacies can only do more if they are able to access the funding and investment they need.

"We also thank the Expert Panel report for highlighting the staffing challenges in community pharmacy and in particular the recruitment of pharmacists from community settings directly into Primary Care Networks.”

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less